Results for 'Drug Development'
MSL Talk: Tom Caravela, Steven Stein
How and Why MSLs Bring VALUE to an Organization
MSL role, KOL engagement, drug development process, enhancing medical affairs, strategic direction MSL
In this episode, Steven Stein, senior director of global field medical at Arena Pharmaceuticals, joins the discussion to explore the evolving role of MSLs. He delves into the concept of value within the MSL role and the strategic timing for their involvement in the drug development process. Ste…
Dec 14th • 31 mins listen
MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late
Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization
In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…
Feb 18th • 34 mins listen
Kirk Shepard
Breakthroughs in Oncology Drug Development with Dr. Roy Baynes
How do world-changing cancer treatments go from concept to reality? Tune in and discover how strategy, leadership, and heart unite to change lives in oncology—listen now.
Mar 31st • 28 mins listen
Ramin Farhood
Busting Silos: Building the Future of Oncology Drug Development
In our premiere episode, Dr. Ramin Farhood, along with Dr. Kirk Shepard, shares the origin story behind the Oncology Voice Network (OVN)—a bold vision to unite pharma, biotech, academia, and advocacy, breaking down silos that have slowed progress for years.
Jan 20th • 33 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen
Monty Pal
How a Bold Yes Became a Scientific Breakthrough
City of Hope, Monty Pal, Linda Malkas, AOH1996, Ana Olivia Healy
Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.
Jun 9th • 47 mins listen
Michael Pietrack
How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD
Kirk Shepard, Michael Pietrack, mentor, AI, digital
Join host Michael Pietrack on the PharmaVerse Podcast as he speaks with Dr. Kirk Shepard, Chief Medical Officer of PDS Biotechnology, co-founder of the Medical Affairs Professional Society (MAPS), and creator of the Oncology Voices Network (OVN).
Feb 2nd • 24 mins listen
Kirk Shepard
Trust, Transparency & Timelines: Advancing Cancer Care
Kirk Shepard, Rebecca Goldstein
In episode 2 of the Oncology Voice Network Podcast, Rebecca Goldstein joins Dr. Kirk Shepard to share her vision for the OVN community: a space where real collaboration happens between manufacturers and innovation partners, and both sides learn how to optimize this critical relationship. This is abo…
Feb 3rd • 24 mins listen